AZ sells rights to statin med Crestor to Grünenthal
Grünenthal will pay $320m upfront for the rights
Read More
Tag: Statin
Women at risk from sub-standard heart attack care
New research part funded by the British Heart Foundation has highlighted stark inequalities between the treatment of men and women with heart attack and the effect this is having on survival.
Read More
GPs under-prescribing statins to high-risk patients, study finds
The majority of patients at high risk of cardiovascular disease are not being started on statin therapy, suggests new research published in the British Journal of General Practice.
Read More
‘Momentous’ UK trial to explore statin for MS
Researchers have kicked off a £6 million trial investigating the potential of simvastatin as a treatment for multiple sclerosis.
Read More
- Lario Therapeutics awarded $2.4m to advance calcium channel platform
- Mikrobiomik secures approval for gut‑microbiota therapy for C difficile infection
- Exdensur approved in EU for severe asthma and CRSwNP
- Axol Bioscience acquires Newcells Biotech ophthalmology unit
- Nuclera and leadXpro partner to accelerate structure‑based drug design
